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Elevated apoptosis impairs epithelial cell
turnover and shortens villi in TNF-driven
intestinal inﬂammation
Aimée Parker1, Laura Vaux1, Angela M. Patterson1, Amisha Modasia1, Daniele Muraro2, Alexander G. Fletcher3,4,
Helen M. Byrne5, Philip K. Maini5, Alastair J. M. Watson6 and Carmen Pin 1,7
Abstract
The intestinal epithelial monolayer, at the boundary between microbes and the host immune system, plays an
important role in the development of inﬂammatory bowel disease (IBD), particularly as a target and producer of pro-
inﬂammatory TNF. Chronic overexpression of TNF leads to IBD-like pathology over time, but the mechanisms driving
early pathogenesis events are not clear. We studied the epithelial response to inﬂammation by combining
mathematical models with in vivo experimental models resembling acute and chronic TNF-mediated injury. We found
signiﬁcant villus atrophy with increased epithelial cell death along the crypt-villus axis, most dramatically at the villus
tips, in both acute and chronic inﬂammation. In the acute model, we observed overexpression of TNF receptor I in the
villus tip rapidly after TNF injection and concurrent with elevated levels of intracellular TNF and rapid shedding at the
tip. In the chronic model, sustained villus atrophy was accompanied by a reduction in absolute epithelial cell turnover.
Mathematical modelling demonstrated that increased cell apoptosis on the villus body explains the reduction in
epithelial cell turnover along the crypt-villus axis observed in chronic inﬂammation. Cell destruction in the villus was
not accompanied by changes in proliferative cell number or division rate within the crypt. Epithelial morphology and
immunological changes in the chronic setting suggest a repair response to cell damage although the villus length is
not recovered. A better understanding of how this state is further destabilised and results in clinical pathology
resembling IBD will help identify suitable pathways for therapeutic intervention.
Introduction
Inﬂammatory bowel disease (IBD) is associated with
excessive epithelial death in the ileum and colon1. Recent
ﬁndings suggest a primary role for focal injury of the
epithelial lining and selection for aggressive microbial
communities preceding the establishment of Crohn’s-like
ileitis2–4. Likewise, the murine dextran sodium sulfate
(DSS) colitis model highlights the importance of the
severity of epithelial injury in the establishment of IBD.
Depending on the DSS dose, animals present either severe
intestinal injury with impaired “mucosal healing” and
fatality, or mild injury with rapid restoration of mucosal
integrity5,6. Ultimately, re-establishment of the epithelial
barrier leads to sustained clinical remission and resection-
free survival in IBD patients7.
TNF is a cytokine produced by immune, mesenchymal
and epithelial cells, and regulates the epithelial barrier in
multiple ways, including mucus secretion, barrier perme-
ability, proliferation/differentiation and wound healing8–10.
A single exogenous high dose of TNF induces transient
intestinal damage with rapid epithelial cell apoptosis, pre-
dominantly at villus tips, villus shortening, ﬂuid exudation
into the gut lumen, and diarrhoea8,11–13. Animal models
with persistent elevated TNF exhibit IBD-like inﬂammatory
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changes in the mucosa and are widely used to study
intestinal chronic inﬂammatory processes3,14,15. Such
models reveal the role of epithelial cells as targets and
producers of TNF in apoptotic death, leading to barrier
breach and ultimately to IBD-like pathology16–18.
Numerous studies using TNFRI and TNFRII knockout
mouse models suggest TNF-induced cell apoptosis in
the small intestine is triggered primarily through TNFRI
signalling11,13,18–21. although heterogeneous responses are
detected upon differences in signal transduction down-
stream of the receptor binding22–24. TNFRII can play an
additive role in enterocyte death11,13 or diverse roles in
epithelial cell survival, proliferation and migration, and
immune regulation25–28.
We here investigated epithelial cell dynamics in the
small intestine of experimental mouse models of acute
and chronic intestinal inﬂammation. Acute inﬂammation
was induced by a single intraperitoneal delivery of
recombinant TNF, while chronic inﬂammation was
induced by delivery of a TNF-expressing plasmid, result-
ing in lower, but persistent, levels of circulating TNF
(Fig. 1a). We studied two TNF-responsive regions11,13,29:
the duodenum which, is usually not compromised by IBD,
and the ileum, which exhibits typical lesions during IBD
episodes. We combined cell labelling and tracking tech-
niques with mathematical modelling to quantify cell
dynamics along the crypt-villus epithelial unit (CVEU), a
one-dimensional column of cells running from the base of
a crypt to the tip of an adjoining villus30,31. We used
Bromodeoxyuridine (BrdU) to quantify the progression of
labelled cells along the CVEU, from which we inferred the
absolute cell production rate, henceforth referred to as
epithelial turnover. This rate quantiﬁes the cell yield
resulting from proliferation and death along the CVEU
and differs from the number of cells generated per pro-
liferative cell per unit time, which we referred to as divi-
sion rate. Epithelial turnover depends on the number of
proliferative cells, the division rate, and the rate at which
cells die along the crypt-villus axis. To study each of these
parameters in our experimental models, we combined
mathematical models with BrdU S-phase cell labelling,
Vincristine mitosis arrest, and TUNEL staining. Con-
currently, we measured the intracellular concentration of
TNF and the spatial distribution of TNF receptors along
the CVEU. Applying this methodology, we aimed to gain
insight into the loss of epithelial homoeostasis preceding
IBD development.
Results
TNF causes villus atrophy and prolonged exposure results
in IBD-associated immune changes
Following a single intraperitoneal delivery of rTNF
(0.5 mg/kg) (Fig. 1a), intense cell death and shedding was
seen at villus tips (Fig. 1b). This response peaked around
1–1.5 h post TNF administration, when the concentration
of circulating TNF reached levels of 1200 pg/ml plasma
(Fig. 1b). Shedding cells were TUNEL and cleaved-
Caspase-3 (CC3) positive (Fig. 1c) indicating cell death
by apoptosis. Goblet cell mucus depletion
(MUC2 staining) was also evident at 1–1.5 h post induc-
tion (Fig. 1d). Tip cell shedding was preceded by retrac-
tion of the villus core and constriction of the villus tip
epithelium (Fig. 1b). Within 2–4 h post-injection, the
villus recovered its gross morphology, although not its
original dimensions, while MUC2 depletion persisted
after 12 h (Fig. 1d). Acute single delivery of doses at or
below 0.25 mg/kg had no apparent effect on apoptotic
shedding (data not shown).
We used a TNF-expressing plasmid, delivered by
hydrodynamic tail vein injection (HTVI) to induce low-
level TNF production in our chronic model of inﬂam-
mation. We quantiﬁed circulating TNF at 48 h, 1 week
and 2 weeks post-plasmid delivery and observed constant
average values of 216 ± 82 pg/ml plasma, similar to those
reported in genetically altered mouse models of TNF-
driven intestinal damage, 90–430 pg/ml4,14,15. These
relatively low TNF levels result in no effect if delivered as
a single dose, but lead to pathology if maintained for
longer periods4,14,15. Core retraction, tip constriction and
shedding were not observed in the samples collected post-
induction of chronic injury (Fig. 1b). However, villus
length was signiﬁcantly reduced to a similar extent as in
the acute model (Fig. 1e). Chronic TNF-expressing mice
exhibited decreased CVEU length for the duration of the
treatment, while in the acute model the initial drastic
reduction of villus length was followed by full recovery
(Fig. 1e). Thus, although the villus tips were conﬂuently
covered by epithelial cells and the apoptotic index
returned to control levels, the recovery of the villus tip
was prevented in the chronic setting.
We studied the intestinal immune response by analysing
expression of inﬂammation-associated proteins and
assessing the mucosal immune cell composition with ﬂow
cytometry. Levels of CXCL5, MCP-1 and M-CSF, which
are all involved in recruitment of immune cells to sites of
inﬂammation, were increased in chronic inﬂammation
(Fig. S1A). Flow cytometry analysis showed a shift from
T-effector to T-regulatory proﬁle in chronic inﬂamma-
tion, compared to acute TNF-injured and healthy mucosa
(Figs S1B-S1C).
Chronic inﬂammation decreases epithelial cell turnover
To study whether inﬂammatory cell loss and villus
shrinkage was accompanied by changes in cell production,
we modelled the epithelium as a system of contiguous,
non-compressible cells with an open boundary at the
villus tip. This dictates that the excess of cells proliferating
within the crypt migrate towards the tip, along the
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crypt-villus axis. Thus, after a single BrdU injection, the
spatial progression of the labelled front along the CVEU
reﬂects the absolute number of cells generated within the
crypt per unit time, as previously reported30,31. We gen-
erated a BrdU labelling dataset by injecting a single dose
of BrdU and sampling repeatedly in the following 48 h for
both the acute and chronic models (Fig. 1a) and used it to
ﬁt equation (2) and estimate the epithelial turnover as
described in the supplementary material. Figure 2a shows
the predicted and observed progression of the BrdU-
labelled cell front on the villus in each mouse model. Fits,
diagnosis plots and posterior parameter estimates are
shown in Fig. S2 and Table S1.
Although epithelial turnover was apparently unaf-
fected by acute inﬂammation in either duodenum or
ileum (Fig. 2b; Table S1), we consider this result
inconclusive because the BrdU tracking period required
for this estimation exceeded the duration of the acute
inﬂammation process. On the other hand, cell produc-
tion rates in chronic inﬂammation were signiﬁcantly
reduced compared to healthy intestine (Fig. 2b;
Table S1), suggesting sustained inﬂammation inhibits
the intestine’s ability to maintain healthy epithelial
turnover. To validate our chronic setting, we used an
equivalent model of long-term low-dose TNF delivered
by subcutaneous osmotic minipumps, achieving similar
plasma levels of 146 ± 97 pg/ml. We observed similar
reduction in cell production in these two chronic
models (Fig. S3A), supporting the hypothesis that rela-
tively low levels of circulating TNF maintained for long
periods results in decreased epithelial turnover.
As mentioned above, the cell production rate reported
in this section is an estimation of the absolute number of
cells generated per hour in the CVEU or epithelial
turnover. In the following sections we investigated
whether the reduction of epithelial turnover in the
chronic setting was due to decreased number of pro-
liferative cells, increased cell death, and/or a longer
division cycle.
The size of the proliferative compartment is not affected in
either acute or chronic inﬂammation models
We found that Ki-67 protein detection did not provide
an accurate estimation of the size of the proliferative
compartment in mouse small intestinal epithelium
(Figs S3C- S3D). To calculate the number of proliferative
cells in the crypt, we, therefore, administrated a combi-
nation of vincristine sulphate to halt cell division during
metaphase, leaving visible mitotic ﬁgures, and BrdU to
label cells in S phase. Vincristine arrested the division
cycle of all cells entering metaphase for a period of 8 h
post-injection (data not shown). BrdU was administered
together with the initial vincristine injection and
approximately every 2 h thereafter to label cells already in,
or entering, S-phase over the following 8 h (Fig. 2c). The
total number of BrdU-labelled cells and/or cells in
arrested metaphase provided an estimate of the number of
proliferative cells along the CVEU (Fig. 2d). This strategy
prevented overestimation of proliferative cells by halting
cell division of BrdU-labelled cells. Unlike Ki-67 labelled
cells, which are detected on the villus (Figs S3C-S3D),
BrdU-labelled cells and cells in arrested metaphase were
detected only in the crypt region in all our tissue samples
(Fig. 2d). Slowly cycling cells in which the length of G1
is <7 h and/or the length of G2 is greater than 8 h may not
all be visualised with this technique. However, the
reported timescales for the cell cycle phases in mouse
crypts32,33 indicate that our vincristine/BrdU delivery
strategy likely capture most proliferating cells in the crypt.
Our results showed no differences in the size of the
proliferative compartment between duodenum and ileum in
control animals (Fig. 2e). During TNF-mediated inﬂam-
mation, we observed a higher number of proliferative cells
in acute inﬂammation in the duodenum, but not the ileum,
and no signiﬁcant effect on the number of proliferative cells
was seen in chronic inﬂammation (Fig. 2e). These results
suggest that the reduced cell production observed in
chronic inﬂammation is not associated with a decrease in
the number of proliferative cells within the crypt.
(see ﬁgure on previous page)
Fig. 1 Changes in the small intestinal epithelium of acute and chronic TNF-mediated injury mouse models. a Schematic of experimental
treatment and sampling timeline for acute and chronic TNF-mediated inﬂammatory injury. b Morphology of duodenal sections illustrating epithelial
disruption 1–4 h following a high-dose pulse of TNF (acute model) with concomitant BrdU administration (brown staining), counterstained
with Haematoxylin (blue/purple). Arrows indicate the hollow villus tips following stromal retraction induced by TNF and the constriction of the
epithelium over the stroma preceding the shedding of the tip, which is re-epithelised at 4 h post-TNF. The epithelium in healthy and chronic
inﬂammation models exhibits standard morphological appearance. Progression of BrdU-labelled cells on the CVEU over time was used to quantify
cell dynamics in later analyses. c Images of TUNEL and cleaved-Caspase-3 (CC3) labelled duodenum sections illustrating labelling similarity and
differences in cell death intensity along the CVEU of healthy and inﬂammation mouse models. d Representative images and quantiﬁcation of cells
staining positive for goblet cell mucin (MUC2) in small intestine of control and acute inﬂammation mouse model at 1, 1.5, and 12 h post-TNF delivery.
e Plot symbols show the decrease and recovery of the CVEU length (average number of cells ± standard deviation) in duodenum and ileum over
time following the administration of one high-dose pulse of TNF (acute inﬂammation). Continuous blue and red bands show the average ± standard
deviation of the CVEU length in control conditions and the chronic inﬂammation model, respectively
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Cell apoptosis increases along the inﬂamed villus and
mainly at the villus tip
We observed TUNEL and cleaved-caspase-3 (CC3)
positive cells mainly on the villus tips of both inﬂamma-
tion models indicating cell death by apoptosis in agree-
ment with previous reports8,11 (Fig. 1c). The numbers of
death events increased in both acute and chronic
inﬂammation models with respect to healthy conditions
(Fig. 3a). While the majority of dying cells were located at
the villus tips, inﬂammation also increased the number of
death events along the villus body (Fig. 3b). An increase in
cell death in crypts cannot be clearly concluded from our
data as it was signiﬁcant only in the ileum of the chronic
setting (Fig. 3b, Table S2).
We then quantiﬁed the temporal dynamics of cell death
along the crypt-villus axis. The estimation of death rates
enabled the further assessment, as detailed below, of whe-
ther the decreased epithelial turnover observed in chronic
inﬂammation is associated with increased cell death. We
developed a mathematical model which assumes that death
commences when cells become TUNEL-positive and cul-
minates in cells detaching from the epithelium (equations
(6–7) in supplementary material). The model considers two
cell ‘compartments’, (i) healthy cells and (ii) TUNEL-
positive cells, and describes how the number of cells in each
compartment changes over time, as healthy cells die,
detach, and are lost from the system. The parameters
governing these dynamics are the rate of death of healthy
Fig. 2 Quantiﬁcation of the impact of chronic and acute inﬂammation on the CVEU cell production rate and on the size of the proliferative
compartment. a Observed (symbols) and predicted (continuous lines; equation [1] in supplementary material) position of the BrdU-labelled front
(LF) over time on the CVEU in homoeostasis and acute and chronic inﬂammation mouse models. b Comparison of the CVEU cell production rate
(cells/h) in control conditions with that observed in chronic and acute inﬂammation conditions. Stars denote statistically signiﬁcant differences.
c Cartoon representative of the cell cycle with BrdU uptake and metaphase arrest by vincristine administration and administration schedule of
vincristine and BrdU devised to detect proliferative cells. d Number of BrdU-labelled cells, cells in arrested metaphase, BrdU-labelled cells in arrested
metaphase and proliferative cells at each position of the CVEU in duodenum and ileum of healthy mice. e Number of proliferative cells in the CVEU of
duodenum and ileum in healthy and inﬂammation mouse models. Stars denote statistically signiﬁcant differences between groups according to a
Tukey test
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cells and the rate of detachment of apoptotic cells (equa-
tions (6–7)). Identiﬁcation of parameter values is described
in the supplementary material. Model ﬁts, estimates and
errors are given in Fig. 3c, Tables S3 and S4, and Fig. S4.
Cell loss in duodenal and ileal CVEUs (~27 and 8 cells,
respectively) during the ﬁrst hour of acute inﬂammation
(Fig. 3d) is not compensated by cell production (~1.6 and
1.2 cells/h respectively, Fig. 2b, Table S1) resulting in
the loss of the villus tips in our acute model (Fig. 1e).
Death rates were also increased in the villus body and tip
in the chronic setting compared to healthy epithelium,
with higher rates in the tip than in the villus body
Fig. 3 Cell death quantiﬁcation along the CVEU of chronic and acute inﬂammation mouse models using TUNEL staining. a Proportion of
TUNEL-positive cells at each position of the CVEU in duodenum and ileum at several sampling times during acute inﬂammation and in chronic
inﬂammation and healthy mouse models. b Average number of TUNEL-positive cells counted in the crypt, villus body and villus tip in the ileum and
duodenum of healthy and inﬂammation mouse models. Stars denote statistically signiﬁcant differences. c Observed (symbols) and predicted
(continuous lines; equations [8–9] in supplementary material) number of TUNEL-positive (black) and -negative (red) cells over time on the CVEU in the
duodenum and ileum within the ﬁrst 1.5 h of the acute inﬂammation process. d Estimates of the cell death rate (h−1) in the crypt, villus body and
villus tip of healthy mice, chronic inﬂammation mouse models and during the recovery from acute inﬂammation (6 h post-acute inﬂammation)
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(Table S4 and Fig. 3d). As observed in the acute setting,
the high death rate at the villus tip cannot be compen-
sated by cell proliferation and is responsible for the
shortening in villus length, which does not recover while
circulating TNF levels are elevated. On the other hand,
sustained increased cell loss in the villus body is balanced
by proliferation, which prevents further reduction of the
villus length, but results in reduced epithelial cell turnover
in the chronic setting (Fig. 2b).
Cell division is not affected by chronic TNF-driven injury
We next asked whether altered cell cycle duration could
be partly responsible, together with increased apoptosis
along the villus body, for the reduced cell turnover
observed in our chronic setting. To do this, we described
the temporal dynamics of BrdU labelling along the CVEU
with a three-compartment model34. Two compartments
comprise crypt cells: one with proliferative cells and the
other with non-proliferative cells; the third compartment,
or villus compartment, contains all remaining non-
proliferative cells of the CVEU (Fig. 4a). We assumed
that following a single BrdU injection, proliferative and
non-proliferative BrdU-labelled cells are generated within
the crypt and transferred onto the villus once they reach
the crypt-villus boundary; labelled cells migrate upwards
until they are shed from the villus tip. With this model, we
evaluated the effect of inﬂammation on the division rate
of the crypt proliferative population. The unambiguous
identiﬁcation of the value of parameters in equations
(16–23) was achieved using experimental results from
previous sections and BrdU labelling datasets (supple-
mentary material). Fitting diagnosis plots and parameter
estimates can be found in Fig. 4b, Fig. S5 and Table S5.
The division rate was faster in duodenum than in ileum
(Fig. 4c). We did not observe changes in cell cycle dura-
tion during chronic or acute inﬂammation (Fig. 4c). As
mentioned above, this result is inconclusive for the acute
setting because the BrdU measurement period exceeds
the duration of the acute inﬂammation process. Our
results indicate that during chronic TNF-driven inﬂam-
mation, a decrease in the overall epithelial turnover is
associated with increased cell death in the villus body
while cell division or number of proliferative cells in the
crypt is not affected. Cell proliferation within the crypt
does not respond to compensate for increased cell death
on the villus body or to ameliorate the permanent loss of
the villus tip.
The villus tip exhibits elevated intracellular TNF and
increased TNFRI expression in response to a pulse of TNF
To gain insight into the mechanisms driving apoptotic
responses on the villus, we analysed the intracellular
concentration of TNF and the expression of TNF recep-
tors I (TNFRI) and II (TNFRII) along different regions of
the CVEU. Following a single acute TNF injection, we
detected variation in intraepithelial levels of TNF, with
an increasing concentration from villus base to tip. Levels
of intracellular TNF in villus tips were ~100-fold higher
than in healthy mice (Fig. 5a). The detection of high levels
of intracellular TNF soon after administration (1–1.5 h)
indicates that progressive accumulation of TNF as cells
migrate towards the villus tip is not likely to be con-
tributing to intraepithelial gradient formation. It seems
more plausible that cells located at the villus tip produce
or internalise more TNF than in other CVEU regions.
Immunoﬂuorescence staining for TNFRI (Fig. 5b–h) in
healthy tissues did not reveal an expression gradient along
the crypt-villus axis, suggesting TNFRI distribution does
not explain tip predisposition to TNF-induced death
(Fig. 5b). In homoeostasis, TNFRI expression is pre-
dominantly located in crypt cells, particularly Paneth
resembling cells, in villus cells with secretory cell
appearance and in lamina propria cells (Fig. 5c). In
chronic inﬂammation we observed similar patterns of
TNFRI expression to homoeostasis (Fig. 5d), however at
the peak of acute inﬂammation (1–1.5 h post-TNF deliv-
ery), we found a distinctive expression pattern with
TNFRI-positive cells located on the villus tip, at sites of tip
constriction and at damaged and shedding villus extre-
mities (Fig. 5e). At later time points, when tip morphology
is recovered, clusters of TNFRI-positive cells could still be
detected on the villus tip (Fig. 5f), suggesting cells remain
sensitised to TNF for some time after intense tip shedding
ceases. Dissimilarly, we found TNFRII expression was
induced by both acute and chronic TNF delivery
(Fig. 5i–p) and was widespread in cells along the CVEU
(Fig. 5i–n).
Altogether, these results indicate that cells on the villus
tip respond rapidly to TNF by upregulating TNFRI and
TNFRII. TNFRI spatial pattern of upregulation is asso-
ciated with elevated intracellular levels of TNF and cell
apoptosis, which results in rapid loss of the tip in acute
inﬂammation. We hypothesise that the maintenance of
elevated circulating TNF impairs the recovery of the TNF-
sensitive villus tips in our chronic injury model, in which
we observe recovered epithelial continuity but reduced
villus length.
Discussion
The integration of labelling techniques with mathema-
tical models here demonstrated a lack of proliferative
compensatory response to chronic inﬂammation. In other
reports, proliferative responses to sustained epithelial
injury are reported in the colon, but vary with species and
injury model. Increased proliferation and apoptosis is
reported in DSS colitis in rats35, while DSS injury is
reported to increase apoptosis, but decrease proliferation
in BALB/c mice36. Increased cell migration but unaffected
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proliferation is reported in DSS-treated colon37. In a
surgical biopsy injury model, increased proliferation was
reported exclusively in the colonic crypts adjacent to the
site of biopsy38.
Fig. 4 Estimation of the division rate of crypt proliferative cells during chronic and acute inﬂammation mouse models using BrdU label
dynamics and previously gathered information on cell death rates and number of proliferative cells. a Schematic of the three-compartment
model developed to quantify the temporal dynamics of the BrdU labelling along the CVEU (equations [13–15]). Two of the compartments contain
exclusively crypt cells, one with proliferative cells and the other one with non-proliferative cells. The third compartment is the villus compartment,
which contains all remaining non-proliferative cells of the CVEU. Following a single BrdU injection, proliferative and non-proliferative BrdU-labelled
cells are generated within the crypt and transferred onto the villus once they reach the crypt-villus boundary. Cell death may cause loss of cells from
these compartments. Cell shedding of labelled cells from the villus tip starts after labelled cells reach the tip of the villus. b Experimental observations
(circles) and three-compartment model predictions (lines) of the number of labelled cells over time in the crypt and villus in the duodenum and
ileum of control mice and of acute and chronic inﬂammation mouse models. Dashed and dotted lines represent the predicted number of
proliferative and non-proliferative cells, respectively, in the crypt. c Comparison of the cell division rate, λ (h−1), of the crypt proliferative compartment
of duodenum and ileum in control mice and in acute and chronic inﬂammation mouse models. Stars denote statistically signiﬁcant differences
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We found increasing TNF intracellular concentration
toward the villus tip in acute inﬂammation (Fig. 5a). We
also saw TNFRI expression localised to tip epithelial cells.
It is not clear whether endogenous epithelial-produced
TNF or exogenous TNFRI-bound TNF determines tip
sensitivity, but it is clear that the response to TNF sig-
nalling is more intense in tip cells. Differential expression
of TNF-triggered signalling pathways, including MAPK
signalling24,39 and the detection of pro-apoptotic cleaved
villin fragments speciﬁcally in tip cells40, have also been
implicated in TNF-regulated cell death. Upregulation of
these factors may be promoted by signalling from tip-
localised subsets of sub-epithelial myoﬁbroblasts, which
are morphologically and phenotypically distinct from
ﬁbroblasts located lower in the villus body41–44.
In chronic inﬂammation, we did not observe tip-
localised expression of TNFRI (Fig. 5c), yet caspase and
TUNEL-positive staining showed increased tip cell death
relative to healthy intestine (Fig. 3b–d). No obvious core
contraction or constriction of the villus tip was observed
in this setting either. these phenomena are likely to be
early events during the onset of chronic inﬂammation.
Thus, TNF-sensitive villus tips were probably lost by the
time of sampling and their recovery impaired by the
sustained shedding of TNFRI-expressing tip cells. Other
authors have also reported different TNFRI expression
patterns in response to acute and chronic inﬂammation18.
The TNFRI staining pattern we observe in homoeostasis
is in agreement with previous reports describing staining
of lamina propria ﬁbroblasts45 and ileal L-cells46, but does
not reproduce conﬂicting descriptions of more wide-
spread apical29 or basolateral24 staining of duodenal epi-
thelial cells. Our ileal TNFRI staining following TNF
challenge is similar to previous reported patterns in
healthy ileum29. Disparities likely reﬂect differences in
animal housing and speciﬁc antibodies used. We detected
widespread TNFRII expression in epithelial cells in our
inﬂammation models in agreement with previous
reports26,47. The differences we observed in TNFRI and
TNFRII staining patterns suggest distinctive location-
speciﬁc regulation which results in co-localisation of
TNFRI, but not of TNFRII, with elevated intracellular
TNF and TNF-induced apoptosis.
In chronic TNF injury, we quantiﬁed that increased cell
death in the villus body and tip was responsible for the
slower epithelial turnover and blunted villi, respectively.
Together with inﬂammatory protein expression analyses
and mucosal immune cell proﬁles, these results suggest a
repair response to cell damage, which leads to villus re-
epithelialisation but fails to recover the original villus
length. What causes this state to further destabilise and
lead to overt clinical pathology resembling IBD in later
weeks4,14 remains to be speciﬁcally determined. Strong
evidence suggests that the microbiota is an essential driver
of IBD development3,4,14, which may explain why we
detect epithelial alterations in both duodenum and ileum
in our chronic setting, whereas subsequent IBD lesions
are reported to affect the ileum and ileocolonic
region3,4,14. Of note is that subclinical lesions detected by
confocal endomicroscopy are reported in the duodenum
of IBD patients48.
In summary, we have developed a strategic combination
of in vivo models, labelling techniques and mathematical
models to assess cell dynamics during acute and chronic
injury aiming to understand the response of the epithe-
lium to inﬂammation. Future detangling of the epithelial
response, and the immune and microbial changes during
the onset of IBD, is essential to discover new strategies for
therapeutic intervention.
Materials and methods
Mice
All animal experiments were conducted in strict
accordance with the Home Ofﬁce Animals (Scientiﬁc
Procedures) Act 1986. Female C57BL/6 mice, aged
10–12 weeks and weighing at least 25 g prior to use in
experiments, were housed and maintained in SPF condi-
tions at the University of East Anglia, Norwich, UK in
accordance with HO regulations, and all procedures were
performed by fully-trained and licenced researchers.
Experimental animals were closely monitored and were
killed by rising CO2 and cervical dislocation, at the time
points described in the text, prior to subsequent tissue
collection. All animals were regularly monitored for
clinical signs; any displaying signs beyond those expected
within the moderate limits of the procedures would be
immediately sacriﬁced by the above methods and were
not included in experimental data. Osmotic minipumps
(Alzet, model 2002, Charles River, Margate, UK) were
inserted subcutaneously to anaesthetised animals.
Inﬂammation induction and BrdU cell labelling
Transient, acute inﬂammation was induced by single
intraperitoneal injection of recombinant murine TNFα
(Peprotech, London, UK) at 0.5 mg/kg. Chronic inﬂam-
mation was initiated by hydrodynamic tail vein delivery of
10 µg TNF-expressing plasmid (pHEP-TNF a kind gift
from C. Gunther, Erlangen, Germany) in a volume of 10%
of body weight in Ringer’s Solution (Braun, Germany).
Alternatively, low-level TNF (Recombinant murine TNFα,
Peprotech, UK) was delivered continuously for 2 weeks at
35 ng/h by subcutaneously implanted osmotic minipump.
The minipump delivery setting was used to validate the
epithelial turnover results observed in the plasmid medi-
ated setting with similar TNF circulting concentrations.
Plasma concentration of TNF was conﬁrmed by speciﬁc
ELISA (Thermo Fisher Scientiﬁc, Waltham, USA) for
elevated levels in blood plasma over a minimum of
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14 days, and in liver and intestinal tissue lysates post-
mortem. The thymine analogue 5-bromo-2-deoxyuridine,
BrdU (Sigma-Aldrich, Paisley, UK) was administered at
50 mg/kg body weight by single intraperitoneal injection.
In the case of acute inﬂammation, the experimental ‘time
zero’ of the BrdU labelling process was set to 2 h after the
single-dose BrdU injection, which we previously demon-
strated to be adequate for all mouse models and
tissue samples30. BrdU was delivered simultaneously with
TNF in the acute injury setting. In the chronic inﬂam-
mation experiments, BrdU time courses were performed
once elevated blood TNF levels had been established
(Fig. 1a).
Vincristine delivery
To halt cells in mitosis, 0.5 mg/kg vincristine together
with 50mg/kg BrdU was delivered by single intraper-
itoneal injection. In the acute model, these two com-
pounds were delivered simultaneously with the injection
of TNF, while in the chronic model vincristine and
BrdU were administered after ~2 weeks of TNF induction,
once elevated plasma levels had been conﬁrmed
by ELISA. BrdU was then delivered at 2.33, 4.66 and 7 h
post-vincristine injection both in the acute and chronic
model (Fig. 2c). Tissues were collected for analysis 8 h
after the initial vincristine injection.
Tissue processing and immunostaining
At sampling time points post BrdU administration, mice
were killed and intestinal tracts were removed, dissected,
formalin-ﬁxed and parafﬁn embedded. Transverse sec-
tions of duodenum and ileum were prepared at 5 μm and
were immunostained for BrdU using biotinylated anti-
BrdU antibody (AbCam, Cambridge, UK), Neutravidin-
HRP (Thermo Fisher Scientiﬁc, Waltham, MA, USA), and
diaminobenzidine reaction (DAB, Dako, Glostrup, Den-
mark). Ki-67-positive cells were detected with Rabbit anti-
Ki-67 and goat-anti-rabbit Alexa-568 (AbCam). TNFRI
and TNFRII labelling was performed on FFPE sections
with rabbit polyclonal antibodies against TNFRI [raised
against mouse TNFR1 aa 29–43, GLVPHLGDREKRDSV
(AbCam)] or against TNFRII [raised against a synthetic
peptide of mouse TNFRII C-terminus aa296–324,
QRDAKVPHVPDEKSQDAVGLEQQHLLTTA (Thermo
Fisher)] followed by secondary labelling with goat-anti-
rabbit-Alexa-568 (Life Technologies). Villus cell apoptosis
was conﬁrmed histologically by Caspase-3 [rabbit anti-
CC3, (R&D Systems, Minneapolis, USA) and goat-anti-
rabbit-HRP, (AbCam)], and general cell death by TUNEL
assay (Click-iT TUNEL Alexa Fluor 488, Thermo Fisher
Scientiﬁc) in FFPE duodenal and ileal sections counter-
stained with H&E or DAPI. Labelled cell counts for BrdU,
Ki-67, caspase 3 and TUNEL were obtained following the
format described in ref. 30. The numbers of labelled and
unlabelled cells were recorded by position, from crypt
base to villus tip, for 30–50 individual hemi crypt-villus
units per tissue section per mouse, with counts recorded
as binary values.
Epithelial cell isolation
Small intestinal epithelial cells were isolated by removal
of whole small intestine which was ﬂushed, opened
longitudinally, washed and cut into small (<1 cm) pieces
which were then sequentially digested by three rounds of
incubation at 37 °C, shaking for 8 min in DPBS/1 mM
HEPES/2 mM EDTA. Detached epithelial cells in the
resulting supernatants were pelleted and resuspended in
IMDM, spun over 40% Percoll layer, aspirated, washed
and re-pelleted, prior to preparation of cell lysates for
protein analysis, as described below.
Protein expression analysis
Cell lysates of isolated epithelial cells or whole small
intestinal tissue pieces (50 mg) were lysed using Lysing
Matrix D ceramic beads (MP Biomedicals, Santa Ana, CA,
USA) and Cell Lytic solution (Sigma-Aldrich) containing
protease inhibitors. Samples were centrifuged at 13,000
rpm for 10min at 4 °C. Supernatants were collected and
total protein concentration determined using the BCA
method (Pierce, Thermo Fisher). Samples were adjusted
to normalise total protein concentration before inﬂam-
matory protein analysis using Mouse Inﬂammation
Fig. 5 Intraepithelial TNF concentration and TNFRI and TNFRII expression in duodenum and ileum during chronic and acute inﬂammation.
a Concentration of TNF in lysates of epithelial cells isolated from the crypt, villus body or villus tip of duodenum and ileum 1–1.5 h after the initiation
of the acute inﬂammatory process vs. control. b–c Representative images of TNFRI staining in duodenal and ileal sections from healthy mice. TNFRI
staining was detected on cells of the lamina propria (blue arrowheads), Paneth cells (yellow arrowheads), and scattered epithelial cells along the villus
body resembling goblet or enteroendocrine cells (white arrowheads). d TNFRI distribution in chronic inﬂammation was similar to controls. e In acute
TNF-treated animals, intense staining was seen in villus tip cells, particularly at sites of tip constriction and shedding at 1–1.5 h post-injection.
f Clusters of TNFRI-positive cells were observed at the villus tip at later time points after shedding ceased. g–h Comparison of TNFRI staining and
secondary-antibody controls in serial sections of control samples (duodenum) and in acute TNF-treated mice (ileum shown). i–n Representative
images of TNFRII staining in duodenal and ileal sections of acute and chronic TNF models and control duodenum. o TNFRII staining in control
duodenum. p Secondary-antibody-only control for TNFRII staining (duodenum from chronic model shown). TNFRI and TNFRII staining shown in red,
nuclei counterstained with Hoescht (blue)30,32.52–54
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Antibody Array (Abcam, Cambridge, UK). Array blots
were imaged using chemiluminescence detection and
imager (Protein Simple, Oxford, UK). Densitometry ana-
lysis of images was performed in Fiji49.
Lamina propria cell isolation and ﬂow cytometry
Lamina propria lymphocytes and myeloid cells were
isolated from small intestine using a method adapted from
Scott et al.50. Brieﬂy, small intestinal pieces (obtained as
above) were incubated at 37 °C for 15 min in HBSS/1 mM
HEPES/2 mM EDTA, washed four times (shaking,
supernatants containing epithelial cells removed) before
collagenase/dispase digestion for 1 h at 37 °C. Super-
natants were ﬁltered, centrifuged, and pellets resuspended
in chilled FACS buffer (DPBS/2% FBS 1mM EDTA)
on ice before antibody staining and ﬂow cytometric
analysis.
For ﬂow cytometry identiﬁcation, gating strategies were
based on those previously described50,51 and are shown
in Fig. S1B. 100,000 cells were analysed per sample. Live/
dead discrimination was determined using Zombie UV
dye (Biolegend, San Diego, CA, USA). Cells were stained
with a panel of immunophenotyping antibodies (Fig. S1C)
for 40min protected from light, at room temperature.
Data were acquired with a BD LSRFortessa ﬂow cyt-
ometer using BD FACSDiva software (BD Biosciences,
San Jose, CA, USA).
Statistical analysis
The mathematical and statistical models developed to
describe temporal cell dynamics in the CVEU
are described in supplementary material. Model para-
meters were estimated using Bayesian inference. Sta-
tistical comparison of our experimental groups was
carried out by simulating the posterior probability
distribution of the difference between model
parameters using Markov Chain Monte Carlo methods
(MCMC). Differences between groups were considered
signiﬁcant when P{parameter (Group i) > parameter
(Group j) | O} > 0.95, where O represents the dataset
used to ﬁt the model.
The signiﬁcance (p-value <0.05) of differences between
means of observed quantities in our experimental mouse
models was assessed by ANOVA followed by a Tukey
multiple comparison test.
Parameter inference and statistical analysis was per-
formed using SAS 9.4
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